Authors:
Anderson, CP
Seeger, RC
Satake, N
Monforte-Munoz, HL
Keshelava, N
Bailey, HH
Reynolds, CP
Citation: Cp. Anderson et al., Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line, J PED H ONC, 23(8), 2001, pp. 500-505
Citation: Cp. Reynolds et Rc. Seeger, Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma, J PED H ONC, 23(3), 2001, pp. 150-152
Authors:
Daniels, JL
Olshan, AF
Teschke, K
Hertz-Picciotto, I
Savitz, DA
Blatt, J
Bondy, ML
Neglia, JP
Pollock, BH
Cohn, SL
Look, AT
Seeger, RC
Castleberry, RP
Citation: Jl. Daniels et al., Residential pesticide exposure and neuroblastoma, EPIDEMIOLOG, 12(1), 2001, pp. 20-27
Authors:
Rudnick, E
Khakoo, Y
Antunes, NL
Seeger, RC
Brodeur, GM
Shimada, H
Gerbing, RB
Stram, DO
Matthay, KK
Citation: E. Rudnick et al., Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer Group study, MED PED ONC, 36(6), 2001, pp. 612-622
Authors:
Cooper, R
Khakoo, Y
Matthay, KK
Lukens, JN
Seeger, RC
Stram, DO
Gerbing, RB
Nakagawa, A
Shimada, H
Citation: R. Cooper et al., Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Histopathologic features - A report from the Children's Cancer Group, MED PED ONC, 36(6), 2001, pp. 623-629
Authors:
Metelitsa, LS
Naidenko, OV
Kant, A
Wu, HW
Loza, MJ
Perussia, B
Kronenberg, M
Seeger, RC
Citation: Ls. Metelitsa et al., Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activateNK cells, J IMMUNOL, 167(6), 2001, pp. 3114-3122
Citation: Pm. Thompson et al., Homozygous deletion of CDKN2A (p16(INK4a)/p14(ARF)) but not within 1p36 orat other tumor suppressor loci in neuroblastoma, CANCER RES, 61(2), 2001, pp. 679-686
Authors:
Goto, S
Umehara, S
Gerbing, RB
Stram, DO
Brodeur, GM
Seeger, RC
Lukens, JN
Matthay, DK
Shimada, H
Citation: S. Goto et al., Histopathology (international neuroblastoma pathology classification) and MYCN status in patients with peripheral neuroblastic tumors - A report fromthe children's cancer group, CANCER, 92(10), 2001, pp. 2699-2708
Authors:
Hoon, DSB
Kuo, CT
Wen, SH
Wang, H
Metelitsa, L
Reynolds, CP
Seeger, RC
Citation: Dsb. Hoon et al., Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow, AM J PATH, 159(2), 2001, pp. 493-500
Citation: Yl. Wang et al., Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors, CLIN CANC R, 6(2), 2000, pp. 551-558
Authors:
Antunes, NL
Khakoo, Y
Matthay, KK
Seeger, RC
Stram, DO
Gerstner, E
Abrey, LE
Dalmau, J
Citation: Nl. Antunes et al., Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus, J PED H ONC, 22(4), 2000, pp. 315-320
Authors:
Maris, JM
Weiss, MJ
Guo, C
Gerbing, RB
Stram, DO
White, PS
Hogarty, MD
Sulman, EP
Thompson, PM
Lukens, JN
Matthay, KK
Seeger, RC
Brodeur, GM
Citation: Jm. Maris et al., Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study, J CL ONCOL, 18(9), 2000, pp. 1888-1899
Authors:
Schmidt, ML
Lukens, JN
Seeger, RC
Brodeur, GM
Shimada, H
Gerbing, RB
Stram, DO
Perez, C
Haase, GM
Matthay, KK
Citation: Ml. Schmidt et al., Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study, J CL ONCOL, 18(6), 2000, pp. 1260-1268
Authors:
Nickerson, HJ
Matthay, KK
Seeger, RC
Brodeur, GM
Shimada, H
Perez, C
Atkinson, JB
Selch, M
Gerbing, RB
Stram, DO
Lukens, J
Citation: Hj. Nickerson et al., Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study, J CL ONCOL, 18(3), 2000, pp. 477-486
Authors:
Seeger, RC
Reynolds, CP
Gallego, R
Stram, DO
Gerbing, RB
Matthay, KK
Citation: Rc. Seeger et al., Quantitative tumor cell content of bone marrow and blood as a predictor ofoutcome in stage IV neuroblastoma: A Children's Cancer Group Study, J CL ONCOL, 18(24), 2000, pp. 4067-4076
Authors:
Ozkaynak, MF
Sondel, PM
Krailo, MD
Gan, J
Javorsky, B
Reisfeld, RA
Matthay, KK
Reaman, GH
Seeger, RC
Citation: Mf. Ozkaynak et al., Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: A Children's Cancer Group Study, J CL ONCOL, 18(24), 2000, pp. 4077-4085
Authors:
Perez, CA
Matthay, KK
Atkinson, JB
Seeger, RC
Shimada, H
Haase, GM
Stram, DO
Gerbing, RB
Lukens, JN
Citation: Ca. Perez et al., Biologic variables in the outcome of stages I and II neuroblastoma treatedwith surgery as primary therapy: A children's cancer group study, J CL ONCOL, 18(1), 2000, pp. 18-26
Citation: Rl. Chen et al., Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating, CANCER IMMU, 48(11), 2000, pp. 603-612
Authors:
Goto, H
Keshelava, N
Matthay, KK
Lukens, JN
Gerbing, RB
Stram, DO
Seeger, RC
Reynolds, CP
Citation: H. Goto et al., Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors, MED PED ONC, 35(6), 2000, pp. 619-622
Authors:
Choi, LMR
Kim, NW
Zuo, JJ
Gerbing, R
Stram, D
Lukens, JN
Matthay, KK
Seeger, RC
Reynolds, CP
Citation: Lmr. Choi et al., Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma, MED PED ONC, 35(6), 2000, pp. 647-650
Authors:
Erdreich-Epstein, A
Shimada, H
Groshen, S
Liu, M
Metelitsa, LS
Kim, KS
Stins, MF
Seeger, RC
Durden, DL
Citation: A. Erdreich-epstein et al., Integrins alpha(v)beta(3) and alpha(v)beta(5) are expressed by endotheliumof high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide, CANCER RES, 60(3), 2000, pp. 712-721